Reference ranges: Organic cation transporter neurotransmitter optimization reference ranges

NeuroResearch Clinics relies exclusively on DBS Labs for urinary serotonin and dopamine organic cation transporter neurotransmitter optimization in natural treatment of disease. DBS Labs is directed by Tom Uncini, MD hospital based pathologist who is dual board certified in laboratory medicine. Dr. Uncini is the medical director of two hospital labs, University of Minnesota Medical Center Mesabi in Hibbing, MN and Cook Hospital in Cook, MN. Dr. Uncini is also on the faculty of the University of Minnesota Medical School. The urinary organic cation transporter neurotransmitter optimization produced by DBS Labs is of hospital caliber. Between Dr. Uncini and his lab manager there are over 50 years of hospital based laboratory experience.

The experience and credentials of the people running DBS Labs stand in stark contrast to the other labs out there attempting to do urinary organic cation transporter neurotransmitter optimization. Other laboratories have no hospital based board certified laboratory medicine pathologist running the lab, no license to practice medicine, no hospital privilege affiliation, no clinic, no patients, and have never treated one patient in clinic. Yet some are holding out that they have the expertise to tell doctors how to treat their patients when the urinary organic cation transporter neurotransmitter optimization results are reported back to the doctor. This may explain why the testing results of these labs do not correlate when the same sample is run on split sample testing by DBS Labs and the non-MD lab. These non-MD labs are the labs that are recommending and inducing licensed medical doctors to get "baseline urinary organic cation transporter neurotransmitter optimization" prior to treatment even though there is no correlation between testing prior to and once taking amino acid precursors.

Pike Lake Duluth photo by Amy Gunthert

Reference Ranges

REFERENCE RANGES

Written by: Marty L. Hinz, MD

President Clinical Research

NeuroResearch Clinics, Inc.

Cape Coral, Florida USA Research Office

Reference Ranges

HOW CAN A organic cation transporter neurotransmitter optimization REFERENCE RANGE ALERT YOU A LAB IS BAD?

How would you know if the serotonin and dopamine baseline urinary organic cation transporter neurotransmitter optimization results are flawed? First look at the reference range reported. This value should represent the lab values obtained in sampling people in the general population off the street. By definition 95% of the labs obtained as baseline urinary organic cation transporter neurotransmitter optimization should be in the reference range, and there should be a uniform distributed across the reference range. Less than 95% of the baseline labs in the reference range of lack of uniform distribution across the reference range is prima fascia evidence of improperly calibrated and/or erroneously reported laboratory testing.

All labs are not the same, if you are going to work in the world of "high complexity labs" a board certified hospital based laboratory pathologist should be in charge to insure valid results are obtained. We have yet to see labs with no hospital based pathologist in charge that generated baseline organic cation transporter neurotransmitter optimization results that were not useful in treatment or research

View Graphic of Flawed Reference Range

REFERENCE RANGES

- organic cation transporter neurotransmitter optimization

- organic cation transporter neurotransmitter optimization-In depth

- organic cation transporter neurotransmitter optimization-Source of urinary neurotransmitters

- organic cation transporter neurotransmitter optimization-Blood brain barrier

- organic cation transporter neurotransmitter optimization-Collection time

- organic cation transporter neurotransmitter optimization-Quality control

- organic cation transporter neurotransmitter optimization-Quality assurance

- organic cation transporter neurotransmitter optimization-Reference ranges

- organic cation transporter neurotransmitter optimization-Flawed results

- organic cation transporter neurotransmitter optimization-Julia Ross

- organic cation transporter neurotransmitter optimization-Baseline testing

- organic cation transporter neurotransmitter optimization-3 phase dosing versus 3 phase response

University of Minnesota Medical School Neurotransmitter Tests paper.

FROM PEER REVIEWED LITERATURE

The response to Tyrosine was more consistent but primarily yielded an unexpected reduction in urinary dopamine excretion. These data indicate that the urinary excretion pattern of neurotransmitters after consumption of their precursors is far more complex than previously appreciated. These data on urinary neurotransmitter excretion might be relevant to understanding the effects of the precursors in other organs.

Both stimulatory and inhibitory effects of dietary 5 HydroxyTryptophan and Tyrosine on urinary excretion of serotonin and dopamine in a large human population

George J. Trachte, Thomas Uncini and Marty Hinz, Department of Physiology and Pharmacology, University of MN Medical School

organic cation transporter neurotransmitter optimization-REFERENCE RANGES

If you need a medical speaker for AMA Category I CME call NeuroResearch Clinics, Inc.

NeuroResearch Clinics, Inc. only deals with and provides information to licensed health care professionals.

keyz keyb

Reference Ranges